Inhaled sargramostim and whole lung lavage (WLL) as therapy of autoimmune pulmonary alveolar proteinosis (aPAP)

Ilaria Campo (Pavia, Italy), Ilaria Campo, Francesca Mariani, Elena Paracchini, Zamir Kadija, Michele Zorzetto, Carmine Tinelli, Giuseppe Rodi, Federica Meloni, Matthias Griese, Bruce Trapnell, Gerhard Scheuch, Bernhard Muellinger, Maurizio Luisetti

Source: International Congress 2016 – Orphan diseases I
Session: Orphan diseases I
Session type: Thematic Poster
Number: 3870
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ilaria Campo (Pavia, Italy), Ilaria Campo, Francesca Mariani, Elena Paracchini, Zamir Kadija, Michele Zorzetto, Carmine Tinelli, Giuseppe Rodi, Federica Meloni, Matthias Griese, Bruce Trapnell, Gerhard Scheuch, Bernhard Muellinger, Maurizio Luisetti. Inhaled sargramostim and whole lung lavage (WLL) as therapy of autoimmune pulmonary alveolar proteinosis (aPAP). Eur Respir J 2016; 48: Suppl. 60, 3870

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled GM-CSF in pulmonary alveolar proteinosis (PAP) patient refractory to plasmapheresis combined with multiple whole lung lavages (WLL)
Source: International Congress 2016 – Orphan diseases I
Year: 2016

Whole lung lavage efficacy in pulmonary alveolar proteinosis (PAP) is influenced by the infusion volume?
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Whole lung lavage therapy (WLL) of pulmonary alveolar proteinosis (PAP): A global survey of current practices and procedures
Source: International Congress 2016 – Orphan diseases I
Year: 2016

Is it possible to predict the outcome of the whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP)?
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Early effect of whole lung lavage (WLL) on surfactant homeostasis in pulmonary alveolar proteinosis (PAP)
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014



Serum biomarkers as prognostic factors of autoimmune pulmonary alveolar proteinosis after whole lung lavage
Source: International Congress 2016 – Orphan diseases I
Year: 2016

Pulmonary alveolar proteinosis (PAP) in exogenous toxic alveolitis (ETA) patients
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015


Surveillance of whole lung lavage for autoimmune pulmonary alveolar proteinosis in Japan
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004

High-dose N-acetylcysteine (NAC) in fibrotic interstitial lung diseases, a retrospective analysis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013

Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study
Source: International Congress 2015 – IIPs: orphan
Year: 2015

Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP)
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015


Pulmonary alveolar proteinosis
Source: Respipedia Article
Year: 2017

Whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP): long-term lung function follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 220s
Year: 2001

Treatment of combined pulmonary fibrosis and emphysema
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016

Lung function and symptom improvement in patients with pulmonary alveolar proteinosis after whole lung lavage or N-acetylcysteine treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 83s
Year: 2005

Analysis of inflammatory networks in interstitial lung disease in patients with rheumatoid arthritis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Transbronchial cryobiopsy for the diagnosis of interstitial lung disease (ILD) – The UK experience
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


LATE-BREAKING ABSTRACT: Efficacy of inhaled N-acetylcystein in patients with interstitial pneumonia
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014